Machine Learning and Computational Chemistry for the Endocannabinoid System.

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Pharmacology

Background:

• Drug discovery and design are significantly advanced by computational methods.
• Machine learning (ML) is increasingly vital in modern medicinal chemistry.
• The endocannabinoid system (ECS) is a complex target for therapeutic intervention.

Purpose of the Study:

• To provide a structured overview of computational chemistry's role in interrogating the ECS.
• To highlight current computational methods applicable to ECS drug discovery.
• To forecast future opportunities for ML in ECS research.

Main Methods:

• Structure-based drug design (SBDD).
• Virtual screening (VS) of chemical libraries.
• Ligand-based quantitative structure-activity relationship (QSAR) modeling.
• De novo molecular design.
• Emerging machine learning methodologies.

Main Results:

• Computational methods offer powerful tools for exploring the ECS.
• A range of techniques, including SBDD, VS, QSAR, and de novo design, are applicable.
• Machine learning presents significant potential for advancing ECS drug discovery.

Conclusions:

• Computational medicinal chemistry is essential for efficient ECS drug discovery.
• Integrating advanced ML techniques will accelerate the identification of novel ECS therapeutics.
• Future research should focus on leveraging computational approaches for targeted ECS modulation.